Biographie

  • Né le 09/12/1964 à Trier (Allemagne)
  • Nationalité Allemande
  • Marié

Ulf Nehrbass serves as CEO of the Luxembourg Institute of Health and CEO ad interim of the Integrated Biobank of Luxembourg. He spent his career in translational research focusing on the application of basic research towards unmet patient needs and therapy development. As Director and founder of Institut Pasteur Korea he established one of the first translational drug discovery institutes. The project resulted in the development of Q203, the world’s most potent candidate against tuberculosis, currently in Clinical Phase II. More recently Ulf started Ksilink, a French-German translational centre co-founded by INSERM, Sanofi, the Unversity of Strasbourg and the University of Heidelberg among others. Ksilink uses Artificial Intelligence to develop patient based disease models for drug discovery.

Citation

"Disease is making push-ups by the door." Stephen Rodefer

Carrière

Expériences professionnelles

  • Luxembourg Institute of Health (LIH) Établissement Public

    • Membre de la direction
    • CEO
    • 2017 à aujourd'hui
  • IBBL (Integrated BioBank of Luxembourg) Établissement Public

    • Membre de la direction
    • CEO ad interim
    • 2019 à aujourd'hui
  • Ksilink French German Advanced Translational Center

    • Founder, CEO and Scientific Director
    • 2013 à aujourd'hui
  • Qurient Therapeutics (Seoul, Korea) - (I.P.O. Feb. 2016)

    • Founder, CEO
    • 2008 - 2013
  • Institut Pasteur (Seoul, Korea)

    • Founder, CEO and Scientific Director
    • 2004 - 2013
  • CNRS

    • Research Director (DR2)
    • 1998 - 2004
  • Institut Pasteur - Unité de Biologie Cellulaire du Noyau (Paris, France)

    • Chef d’Unité
    • 1998 - 2004

Associations

Associations professionnelles

  • European Molecular Biology Laboratory

    • Predoctoral fellowship
  • European Molecular Biology Organization

    • Long-term fellowship
  • Boehringer Ingelheim Fonds

    • Long-term fellowship
  • Howard Hughes Medical Institute, The Rockefeller University

    • Research Associate
  • ATIPE

    • Responsable
    • 1997 à aujourd'hui
  • EMBO

    • Member
    • 2005 à aujourd'hui

Formations et distinctions

Rockefeller University (New York, N.Y.)

  • Postdoctoral training, HHMI Research Associate
  • 1992 - 1997

University of Heidelberg

  • Ph.D. program, PhD fellow at European Molecular Biology Laboratory (EMBL), Heidelberg. Graduation (Dr. rer. nat.)
  • 1988 - 1992

Darwin College, University of Cambridge (U.K.)

  • M.Phil. in Biochemistry
  • 1985 - 1987

University of Tübingen

  • Vordiplom - Studies in Biochemistry
  • 1984 - 1985

Airforce (Cologne, Germany)

  • Army Service, FNZdLW, Airforce
  • 1983 - 1984

Gymnasium Konz, Rhld.Pflz. (Germany)

  • 1983 : Abitur

Contact

  • Luxembourg Institute of Health (LIH)
  • 1A-1B, rue Thomas Edison, L-1445 Strassen
  • www.lih.lu

Assistant(e):